South Africa’s inflation rate rose to a three-month high in September, strengthening the case for the central bank

Taking a card to Infinity in Marvel Snap has the chance to create a black-and-white variant, but you have to be persistent and a little lucky.

Break out the brellies

No. 8 Oregon and No. 7 Washington will meet for the first time with both teams ranked in the top 10 in one of the most anticipated Pac-12 games in years

Newly signed Chelsea striker Christopher Nkunku might miss the start of the Premier League season after coming off injured in the team’s final preseason game in the United States

Social media users take note: You'll no longer be able to snap that fall foliage selfie in your autumn attire at one popular Vermont spot

JANESVILLE, Wis.--(BUSINESS WIRE)--Aug 14, 2023--

Alcohol addiction ruins millions of lives every year, but scientists may have found a cure for this terrible affliction. A new treatment for alcohol use disorder (AUD) has been trialled in monkeys with impressive results and, if these translate to human trials, the impact could be monumental. A team of neuroscientists and physiologists from across the US tested a new type of gene therapy to see if they could directly target the underlying brain circuitry associated with sustained heavy drinking. As they noted, in the journal Nature Medicine, people suffering from AUD commonly return to alcohol use even if they attempt to quit. This is largely to do with what’s known as mesolimbic dopamine (DA) signalling – meaning how the central nervous system circuit communicates the feelgood neurotransmitter dopamine. A protein called glial-derived neurotrophic factor (GDNF) is key to keeping these neurons in this reward circuitry functioning. However, experts have found that levels of GDNF are reduced in people with AUD during periods of alcohol abstinence, most notably in a region of the brain called the ventral tegmental area (VTA), as IFLScience notes. Therefore, the researchers decided to test whether using gene therapy to deliver more GDNF to the VTA could help reinforce this crucial dopaminergic signalling and prevent patients from suffering an alcoholic relapse. The team of scientists explained how alcohol consumption in non-addicts prompts the release of dopamine, creating a pleasurable buzz feeling, but chronic alcohol use causes the brain to adapt and stop releasing so much dopamine. “So when people are addicted to alcohol, they don’t really feel more pleasure in drinking,” Dr Kathleen Grant, a senior co-author of the study, said in a statement. “It seems that they’re drinking more because they feel a need to maintain an intoxicated state.” For their research, Dr Grant and her colleagues used eight rhesus macaque monkeys, who were exposed to increasing concentrations of alcohol over four 30-day “induction” periods. The monkeys then had free access to alcohol and water for 21 hours a day for six months, during which they developed heavy drinking behaviours. This was then followed by a 12-week abstinence phase, with the GDNF treatment performed four weeks in for half of the subjects. The gene therapy was delivered using a a viral vector containing a copy of the human GDNF gene injected directly into the primate’s VTA, according to IFLScience. And the results were truly jaw-dropping. “Drinking went down to almost zero,” Dr Grant said. “For months on end, these animals would choose to drink water and just avoid drinking alcohol altogether. They decreased their drinking to the point that it was so low we didn’t record a blood-alcohol level.” The most exciting aspect of their findings is the suggestion that gene therapy could offer a permanent solution for people with the most severe cases of AUD. This will be a welcome glimmer of hope to many, given that some 29.5 million people were diagnosed with AUD in the US alone in 2021, according to the National Institute on Alcohol Abuse and Alcoholism. Of these 29.5 million sufferers, almost a million (894,000) were aged between 12 and 17. It’ll likely be some time before we know for sure whether the gene therapy can be rolled out in humans, but it’s an important first step in tackling this devastating disorder. Sign up for our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Amazon said on Monday that it's investing $4 billion into the artificial intelligence company Anthropic in exchange for partial ownership and Anthropic's greater use of Amazon Web Services (AWS), the e-commerce giant's cloud computing platform.

Credit Suisse AG staff are making preparations to sue the Swiss financial regulator over $400 million of bonuses

President Joe Biden has informed leaders from the 18-member Pacific Islands Forum on Monday that he has heard their warnings about the impact of climate change on their region

New York Yankees manager Aaron Boone vividly remembers the poise and confidence a 16-year-old Jasson Domínguez displayed when he watched him take batting practice at the team’s academy in the Dominican Republic in 2019